Credit Suisse Keeps Their Hold Rating on Charles River Labs (CRL)


In a report released yesterday, Erin Wright from Credit Suisse maintained a Hold rating on Charles River Labs (CRL), with a price target of $110. The company’s shares closed yesterday at $109.75.

According to TipRanks.com, Wright is ranked #632 out of 5103 analysts.

Currently, the analyst consensus on Charles River Labs is a Moderate Buy with an average price target of $144.60.

See today’s analyst top recommended stocks >>

The company has a one-year high of $139.72 and a one-year low of $96.70. Currently, Charles River Labs has an average volume of 377.5K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts